1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ellington Financial Inc. (NYSE: EFC) said it estimates net income of $0.43 to $0.47 per share for the quarter ended June 30, 2025, and expects that to be higher than the prior quarter. The company also estimates book value per share of $13.47 to $13.51 as of June 30, 2025. The figures are preliminary, unaudited, and may change materially before final results are released on August 7, 2025.
Estimated Q2 2025 net income per share: $0.43 to $0.47, a sequential increase from Q1 2025
Estimated book value per share at June 30, 2025: $13.47 to $13.51, including $0.39 per share in dividends declared during the quarter
Company also expects Adjusted Distributable Earnings to rise from Q1 2025
Final Q2 2025 results are scheduled for release on August 7, 2025; PricewaterhouseCoopers has not reviewed the preliminary figures
Wintrust Financial reported record net income of $195.5 million, or $2.78 per diluted share, for the second quarter of 2025, up from $189.0 million, or $2.69 per share, in the first quarter. Net interest income rose to $546.7 million, while the net interest margin eased two basis points to 3.52%. Management said it expects net interest income to rise further in the third quarter.
Second-quarter net income was $195.5 million, or $2.78 per diluted share, versus $189.0 million, or $2.69, in the first quarter of 2025.
Net income for the first six months of 2025 was $384.6 million, or $5.47 per diluted share, compared with $339.7 million, or $5.21, a year earlier.
Net interest income was $546.7 million, up from $526.5 million in the first quarter, while the net interest margin was 3.52%, down from 3.54%.
Provision for credit losses was $22.2 million, down from $24.0 million in the first quarter of 2025.
Medpace reported second-quarter 2025 revenue of $603.3 million, up 14.2% from a year earlier, and GAAP diluted earnings of $3.10 per share, up from $2.75. Net income margin fell to 15.0% from 16.7%, and backlog declined 1.8% to $2,873.6 million, while the company repurchased $518.5 million of its stock in the quarter and issued full-year 2025 guidance.
Q2 2025 revenue $603.3 million, up 14.2% from $528.1 million; GAAP net income $90.3 million, or $3.10 per diluted share, vs. $2.75 a year earlier
Full-year 2025 guidance: revenue $2.420 billion to $2.520 billion; GAAP net income $405.0 million to $428.0 million; diluted EPS $13.76 to $14.53
Q2 share repurchases of 1,754,264 shares for $518.5 million; $826.3 million remained under the program as of June 30, 2025
Amendment No. 9 to the PNC Bank unsecured credit facility, dated July 17, 2025, sets line-of-credit borrowing of up to $10 million
Crown Holdings reported second-quarter 2025 results on July 21, 2025, with adjusted diluted earnings per share up 19% to $2.15 and net sales of $3,149 million. The company raised its full-year 2025 adjusted diluted EPS guidance to $7.10 to $7.50, which signals stronger expected earnings for shareholders.
Q2 2025 adjusted diluted EPS rose 19% to $2.15 from $1.81; reported diluted EPS was $1.56 versus $1.45
Net sales were $3,149 million versus $3,040 million; income from operations was $391 million versus $379 million
Full-year 2025 adjusted diluted EPS guidance raised to $7.10 to $7.50; third-quarter adjusted EPS expected at $1.95 to $2.05
Adjusted free cash flow expected at approximately $900 million for 2025
Calix reported unaudited second-quarter 2025 revenue of $241.9 million, up 10% from the prior quarter and 22% from a year earlier, above its prior guidance of $221.0 million to $227.0 million. GAAP results showed a net loss of $0.2 million, while non-GAAP net income per diluted share was $0.33, above the $0.18 to $0.24 guidance range. For shareholders, the filing also gives third-quarter 2025 guidance of $243 million to $249 million in revenue and non-GAAP net income per diluted share of $0.31 to $0.37.
Q2 2025 revenue was $241.9 million, versus prior non-GAAP guidance of $221.0 million to $227.0 million
GAAP net loss was $0.2 million, or $0.00 per diluted share; non-GAAP net income per diluted share was $0.33
Q3 2025 guidance: revenue $243 million to $249 million; non-GAAP net income per diluted share $0.31 to $0.37
Company repurchased 1.0 million shares in Q2 and ended the quarter with $299.0 million in cash and investments
W. R. Berkley reported second quarter 2025 results on July 21, 2025, with net income to common stockholders of $401.3 million and diluted earnings of $1.00 per share, up from $371.9 million and $0.92 a year earlier. Net premiums written reached a record $3.4 billion, and the company said it returned $223.8 million to shareholders through dividends in the quarter.
Net income to common stockholders was $401.3 million, versus $371.9 million in the second quarter of 2024.
Operating income was $420.5 million, or $1.05 per diluted share, versus $1.02 a year earlier.
The consolidated GAAP combined ratio was 91.6%, compared with 91.1% in the second quarter of 2024; current accident year catastrophe losses were $99.2 million.
Total revenues were $3.67 billion, up from $3.31 billion a year earlier.
Zions Bancorporation reported second-quarter 2025 net earnings of $243 million, or $1.63 per diluted share, up from $190 million and $1.28 a year earlier. Net interest income rose 9% to $648 million and the net interest margin widened to 3.17%, while classified loans were $2.7 billion, up from $1.3 billion a year earlier but down from $2.9 billion in the first quarter.
Net earnings $243 million and diluted EPS $1.63, compared with $190 million and $1.28 in 2Q24
Net interest margin 3.17%, compared with 2.98%; net interest income $648 million, up 9%
Classified loans $2.7 billion, or 4.43% of loans and leases, compared with $1.3 billion, or 2.16%, in 2Q24
Common dividend $0.43 per share; estimated CET1 capital ratio 11.0%, compared with 10.6%
TrustCo Bank Corp NY reported second quarter 2025 net income of $15.0 million, or $0.79 per diluted share, up from $12.6 million, or $0.66 per diluted share, in the second quarter of 2024. Net interest income rose 10.5% to $41.7 million, and the net interest margin widened to 2.71% from 2.53%, so both the core lending income and per-share profit measures improved year over year.
Net income of $15.0 million, or $0.79 diluted EPS, for Q2 2025, versus $12.6 million, or $0.66, for Q2 2024
Net interest income of $41.7 million, up 10.5% from $37.8 million; net interest margin of 2.71%, up 18 basis points
Book value per share of $36.75 at June 30, 2025, up from $34.46 a year earlier; 169 thousand shares repurchased in Q2 2025
Conference call scheduled for 9:00 a.m. Eastern Time on July 22, 2025
Amneal Pharmaceuticals released unaudited preliminary second-quarter 2025 results, with net revenue of $720 million to $730 million and adjusted EBITDA of $180 million to $185 million, both up versus the same period in 2024. The company said it expects to meet or exceed its full-year 2025 guidance, and the figures may change before the final results due August 5, 2025. Separately, director Emily Peterson Alva resigned from the Board and its Audit Committee, effective immediately, which the company said was not due to any disagreement.
Net revenue of $720 million to $730 million, up about 3% from the same period in 2024
Adjusted EBITDA of $180 million to $185 million, up about 13%; income before income taxes of $45 million to $56 million versus $20 million a year earlier
Gross leverage fell to 3.8x and net leverage to 3.7x as of June 30, 2025, from 4.1x and 3.9x at December 31, 2024
Emily Peterson Alva, an Amneal Group designee, resigned from the Board on July 16, 2025; the Amneal Group's board designation right was reduced from six to five
Roper Technologies reported second quarter 2025 revenue up 13% to $1.94 billion, GAAP net earnings up 12% to $378 million, and adjusted DEPS up 9% to $4.87. The company raised its full-year 2025 adjusted DEPS guidance low end to $19.90 from $19.80 and lifted its total revenue growth outlook to about 13% from about 12%, while also announcing an $800 million acquisition of Subsplash expected to close later this month.
Q2 2025 revenue of $1.94 billion rose 13%, with organic growth of 7% and acquisitions adding 6%.
GAAP net earnings were $378 million, up 12%; adjusted DEPS was $4.87, up 9%.
Full-year 2025 adjusted DEPS guidance is $19.90 to $20.05, versus prior $19.80 to $20.05; total revenue growth outlook is about 13%, versus about 12% previously.
Roper signed a definitive agreement to acquire Subsplash for $800 million, with closing expected later in July 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.